Vaccine Weekly
Susan Hasty, Publisher
Table of Contents . . . November 21st, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Vaccine Weekly | Other Publications
AIDS And HIV Vaccine - Viral Protein Alterations Have Similar Impact On HIV, SHIV Specific Antibodies
Melanoma - Irradiated Tumor Cells Activate Immune Response After Vaccination
Allergic Response - Cellular Factors Expand Grass Allergen Vaccine Effectiveness
Bioterrorism - Panel Suggests Federally Supervised Vaccine Labs
Cancer Immunotherapy - New Technique Helps Immune System Detect, Fight Cancer
Prostate Cancer - Drug Shown To Slow Growth Of Tumors In Mice
Vaccine Efficacy - Pentavalent Vaccine As Effective As Individual Vaccines In Pediatric Study
Vaccine Research - Transformed Bacteria Produce HCV-Specific Immune Response In Mice
AIDS And HIV Vaccine - New Details About Epitope Targeted By Potent Monoclonal Antibody
Anthrax - BioPort May Resume Vaccine Production By End Of November
Anthrax - Vaccine Manufacturer Reaches Milestone In Licensing Process With FDA
Appointments - Biogen Announces New Senior Vice President, International
Appointments - Plexus Vaccine, Inc., Appoints Scientific Advisory Board
Bioterrorism - Washington, DC, Veterans Center Tests For Anthrax
Cancer Vaccines - Cyclacel Receives Patent On Drug Target Of Cancer Cell Cycle
Cancer Vaccines - ImClone, Bristol-Myers Squibb Seek FDA Approval Of Erbitux
Colon Cancer - Human Trial Underway Utilizing CEA/TRICOM Vaccine
Drug Development - Article Describes New "Golden Age" Of Antiviral Drugs And Vaccines
Finance - Aastrom Biosciences Reports First Quarter Results
Finance - Biomira Solidifies Cash Position As Phase III Trials Begin
Finance - Genecor Reports Flat Revenues, Decreased Earnings In 3rd Quarter
Finance - Therion Completes $36.5 Million Private Financing For Development
Hemophilia - Researchers Target Liver Cells By Nonviral Compacted DNA Complexes
Human Papillomavirus - Vaccine Successful In Phase IIa Clinical Trials
Influenza - Shire Biologics Contracts With Canadian Government To Prevent Pandemic
Meningococcal Group C Vaccine - Shire Biologics Signs Distribution Pack With Baxter Corp.
Mergers and Acquisitions - Select Therapeutics, Cytomatrix, Terminate Their Joint Venture
Ovarian Cancer - Foreign Antibody Approach Clinical Data Presented At Conference
Ovarian Cancer - Monoclonal Antibody Therapy Presented To European Researchers
Respiratory Syncytial Virus - Prophylaxis Reduces Hospitalizations In High-Risk Infants
Rheumatoid Arthritis - Human Monoclonal Antibody Clinical Trials Initiated
Smallpox - Aventis Announces Support For Government Emergency Preparedness Efforts
Smallpox - Drug Firms Confirm They May Be Chosen To Develop Vaccine
Vaccine Development - National Group Supports Removing Mercury From Vaccines
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
